Purchase Order 75N91024P00350
Award Date
3/26/24
Potential Completion Date
6/26/24
Potential Value
$17K
Federal Agency
National Cancer Institute
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, was issued by the National Cancer Institute, a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $4,217.03 firm fixed-price delivery order is for peptide services and does not have a set-aside designation. Genscript is a major provider of molecular biology products and services to federal agencies, including the NIH, Centers...
This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, is for the provision of a wide range of molecular biology products and services to support biomedical research and public health initiatives. The $19,395.39 firm fixed-price purchase order contract, awarded by the National Institute of Child Health and Human Development (NICHD), covers gene synthesis, cloning, protein expression and purification, antibody production, and other...
This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...
This federal contract award, valued at $4,263.55, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in New Jersey. The contract is for the provision of various molecular biology products and services, including gene synthesis, gene editing, custom protein and antibody production, to support biomedical research and public health initiatives. While...
This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,342.69 firm fixed-price purchase order was awarded to Genscript USA Inc., a biotechnology company based in New Jersey, for gene synthesis and plasmid preparation services. The contract did not have a set-aside designation. Genscript has received numerous prime and...
This federal contract award is to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, for $3,903.76. The contract is a delivery order with a firm fixed price, awarded by the National Cancer Institute, which is a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract is for "Peptide Services" and does not have a set-aside designation. Genscript, a for-profit organization, has received...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Genscript USA Inc., a biotechnology company, for gene synthesis services. The $17,000.35 contract has a completion date of December 30, 2020 and was awarded on December 31, 2019. The services provided under this contract supported biomedical research and public health initiatives carried out by the agency. Genscript has...
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), an agency within the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $3,418.30 contract is for the provision of peptide services, including gene synthesis, protein production, and antibody development, to support biomedical research and public health initiatives. While the contract does not have a set-aside designation,...